전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
adjunctive therapy
papildinoša
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
keppra is indicated as adjunctive therapy
keppra indicēts papildterapijai šādos gadījumos:
마지막 업데이트: 2017-04-26
사용 빈도: 4
품질:
levetiracetam sun is indicated as adjunctive therapy
levetiracetam sun indicēts papildterapijai šādos gadījumos:
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
levetiracetam actavis is indicated as adjunctive therapy
levetiracetam actavis indicēts papildterapijai šādos gadījumos
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
adjunctive treatment of homocystinuria, involving deficiencies or defects in:
homocistinūrijas papildterapija, ja ir:
마지막 업데이트: 2012-04-10
사용 빈도: 1
품질:
clinical efficacy of adjunctive retigabine therapy in partial onset seizures
retigabīna papildterapijas klīniskā efektivitāte parciālu krampju gadījumā
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
in addition, the patients were allowed to receive specified adjunctive therapies.
turklāt pacienti drīkstēja saņemt noteiktu papildu terapiju.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
no clinical data are available on adjunctive use with other ocular hypotensive medications.
nav pieejami klīniski dati par travatan lietošanu papildus terapijā ar citiem hipotensīvajiem acu līdzekļiem.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
- adjunctive or monotherapy treatment of partial seizures and generalised seizures, including
- kombinētā terapija vai monoterapija parciālu krampju un ģeneralizētu krampju lēkmju, tajā
마지막 업데이트: 2012-04-10
사용 빈도: 2
품질:
for adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.
akūta mastīta ārstēšanas palīgterapijai kombinācijā ar antibakteriālo terapiju.
마지막 업데이트: 2017-04-26
사용 빈도: 4
품질:
unfractionated heparin and enoxaparin have been used as antithrombotic adjunctive therapy in clinical studies with metalyse.
klīniskos pētījumos ar metalyse antitrombotiskai papildterapijai izmantoja nefrakcionēto heparīnu un enoksaparīnu.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
association between azopt and miotics or adrenergic agonists has not been evaluated during adjunctive glaucoma therapy.
azopt un miotisko vai adrenerģisko agonistu līdzekļu saistība papildinošas pretglaukomas terapijas laikā nav tikusi novērtēta.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
adjunctive therapy with valproate (inhibitor of lamotrigine glucuronidation – see section 4.5):
papildinošā terapija kopĀ ar valproātu (lamotrigīna glikuronizācijas inhibitors — skatīt apakšpunktu 4. 5):
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
the most common adverse reactions in controlled adjunctive-therapy studies were somnolence, dizziness and anorexia.
visbiežākās blakusparādības kontrolētajos papildu terapijas pētījumos bija miegainība, reibonis un anoreksija.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
for the adjunctive use of verteporfin photodynamic therapy (pdt) and lucentis, see section 5.1.
par verteporfīna fotodinamiskās terapijas (pdt) papildus lietošanu lucentis skatīt apakšpunktu 5. 1.
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
concomitant use of lumigan and antiglaucomatous agents other than topical beta-blockers has not been evaluated during adjunctive glaucoma therapy.
netika izvērtēta lumigan un citu pretglaukomas līdzekļu, izņemot topiskos beta blokatorus, vienlaicīga lietošana papildinošas glaukomas ārstēšanas laikā.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
in patients undergoing pci, standard procedural adjunctive therapy should be implemented (see section 5.1).
pacientiem, kuriem veic pki, jāpiemēro standarta papildinošā terapija (skatīt 5.1 apakšpunktu).
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
adjunctive treatment of homocystinuria, involving deficiencies or defects in: cystathionine beta-synthase (cbs),
homocistinūrijas papildterapija, ja ir: cistationīna bēta-sintāzes (cbs),
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
for adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis- metritisagalactia syndrome) with appropriate antibiotic therapy.
lietojot kā palīgterapiju, ārstējot pēcatnešanās septicēmiju un toksēmiju (mastīta-metrīta-agalaktijas sindromu) kombinācijā ar atbilstošu antibakteriālo terapiju.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
adjunctive aripiprazole demonstrated superiority over placebo on the secondary outcome measure, cgi-bp severity of illness score (mania).
aripiprazola papildterapija demonstrēja pārākumu salīdzinājumā ar placebo, izvērtējot sekundāro mērķa kritēriju – cgi-bp slimības smaguma punktu skaitu (mānija).
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질: